http://www.mmm-online.com/rems/topic/9860/ Articles tagged with REMS from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no GSK's Avandia woes continue, study finds a new way to identify adverse events, and Royalty ups its bid for Elan. http://www.mmm-online.com/business-briefs-glaxosmithkline-adverse-event-reporting-elan/article/288927/ Mon, 15 Apr 2013 17:04:06 GMT GSK's Avandia woes continue, study finds a new way to identify adverse events, and Royalty ups its bid for Elan. MMM The FDA's opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency's scheme educate enough physicians to curb an epidemic? http://www.mmm-online.com/fda-opioid-plan-directs-funding-for-cme/article/249828/ Wed, 11 Jul 2012 17:08:41 GMT The FDA's opioid REMS safety plan is challenged on two fronts: getting CME providers to offer courses and getting doctors to attend them. Can the agency's scheme educate enough physicians to curb an epidemic? MMM A potentially dangerous and oft-abused class of painkillers will be required to have REMS risk management programs in place under an FDA edict covering all extended release and long-acting opioid analgesics, a category covering 30 drugs manufactured by 20 companies. http://www.mmm-online.com/company-news-rems-for-purdue-pfizer-and-janssen-painkillers/article/249505/ Mon, 09 Jul 2012 19:38:20 GMT A potentially dangerous and oft-abused class of painkillers will be required to have REMS risk management programs in place under an FDA edict covering all extended release and long-acting opioid analgesics, a category covering 30 drugs manufactured by 20 companies. MMM The general consensus surrounding the FDA advisory panel's 8-2 vote in favor of Pfizer's rheumatoid arthritis hopeful tofacitinib yesterday was that Abbott's Humira doesn't have to watch its back. http://www.mmm-online.com/humira-on-solid-ground-analysts-say-despite-vote-on-pfizer-hopeful/article/240489/ Thu, 10 May 2012 14:48:26 GMT The general consensus surrounding the FDA advisory panel's 8-2 vote in favor of Pfizer's rheumatoid arthritis hopeful tofacitinib yesterday was that Abbott's Humira doesn't have to watch its back. MMM The FDA approved Bristol-Myers Squibb's cancer biologic Yervoy (ipilimumab) for the treatment of late-stage melanoma, a particularly deadly form of skin cancer for which treatment options are few. One analyst projected that sales of the drug could top $1.7 billion by 2015. http://www.mmm-online.com/fda-approves-bms-skin-cancer-biologic-yervoy/article/199258/ Fri, 25 Mar 2011 19:22:36 GMT The FDA approved Bristol-Myers Squibb's cancer biologic Yervoy (ipilimumab) for the treatment of late-stage melanoma, a particularly deadly form of skin cancer for which treatment options are few. One analyst projected that sales of the drug could top $1.7 billion by 2015. MMM Covidien launched a patient safety organization - the Collaborating & Acting Responsibly to Ensure Safety (CARES) Alliance - today, featuring tools and resources for patients, physicians and pharmacists. http://www.mmm-online.com/covidien-launches-opioid-patient-safety-alliance/article/178475/ Wed, 08 Sep 2010 18:39:38 GMT Covidien launched a patient safety organization - the Collaborating & Acting Responsibly to Ensure Safety (CARES) Alliance - today, featuring tools and resources for patients, physicians and pharmacists. MMM